LITAK 2 mg/ml solution for injection

LITAK contains the active substance cladribine. Cladribine is a cytostatic agent. It affects the growth of malignant (cancerous) white blood cells which play a role in hairy cell leukaemia. LITAK is used to treat this disease. Mehr

Producer: Lipomed GmbH

Therapeutic group: Antineoplastic agents

Cookies help us deliver our services. By using our services, you agree to our use of cookies. OK